Key result
The Benchmark Counterpulsation Outcomes Registry demonstrated high validity, with ≥95% agreement for most categorical variables and ≥80% agreement for quantitative variables.
Answers are grounded in this paper and cite their sources.
The Benchmark Counterpulsation Outcomes Registry is a valid and robust tool for tracking IABP use and outcomes.
The Benchmark Counterpulsation Outcomes Registry is a computerized database that incorporates prospectively gathered data on indications for intra-aortic balloon counterpulsation (IABP) use, patient demographics, concomitant medications and in-hospital complications and outcomes. This report summarizes the validation of the Benchmark Registry. Three audits were performed on the Registry data – the first by the sponsor and the second two by independent auditors. The data for categorical variables that could be answered by checking a box were extremely robust, with most items having at least a 95% agreement rate (except catheter size, which had an 82% agreement rate). The data were slightly less robust for quantitative variables that required a written answer (at least an 80% agreement rate). This high agreement rate supports the conclusion that the Benchmark Counterpulsation Outcomes Registry data are generalizable and suggests that the Registry is a powerful tool for tracking the evolving practice of IABP use, including indications, insertion characteristics, duration, complications and outcomes in patients undergoing IABP.
No takes yet. Share an insight, caveat, or question.
Ohman et al. (2003) studied this question. The Benchmark Counterpulsation Outcomes Registry demonstrated high validity, with ≥95% agreement for most categorical variables and ≥80% agreement for quantitative variables.
Synapse has enriched 10 related papers. Consider them for comparative context: